ABSTRACT
The results of treatment of 1231 women patients with the mammarial gland cancer of initial stages was analysed, in 151 of them the organ-preserving operation was performed. The results of treatment with five-year follow-up, using the organ-preserving operations do not cede to such in application of classical mastectomy.
Subject(s)
Breast Neoplasms/surgery , Adult , Female , Humans , Middle Aged , Neoplasm Staging , Quality of LifeSubject(s)
Breast Neoplasms/surgery , Lymph Node Excision , Mastectomy, Segmental , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/mortality , Breast Neoplasms/pathology , Chemotherapy, Adjuvant , Female , Humans , Lymphatic Metastasis , Middle Aged , Neoplasm Staging , Radiotherapy, Adjuvant , Retrospective Studies , Treatment Outcome , Ukraine/epidemiologySubject(s)
Breast Neoplasms , Lung Neoplasms/secondary , Adult , Aged , Breast Neoplasms/diagnosis , Breast Neoplasms/physiopathology , Female , Humans , Menopause , Middle Aged , Prognosis , Prolactin/blood , Respiration , Risk FactorsABSTRACT
The study included 157 patients with edematous-infiltrative breast cancer. Thermochemo- and thermoradiotherapy were shown to modify (increase) cancer cell sensitivity to antitumor treatment and thus improve tumor response.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/therapy , Edema/therapy , Hyperthermia, Induced , Adult , Aged , Breast Neoplasms/complications , Breast Neoplasms/mortality , Combined Modality Therapy , Drug Therapy, Combination , Edema/etiology , Female , Glucose/administration & dosage , Hormones/therapeutic use , Humans , Hyperthermia, Induced/methods , Magnetics/therapeutic use , Middle Aged , RadiotherapySubject(s)
Breast Neoplasms/blood , Fibrocystic Breast Disease/blood , Gonadotropins/blood , Prolactin/blood , Aged , Female , Humans , Menopause/blood , Middle AgedSubject(s)
Mastitis/diagnosis , Tuberculosis/diagnosis , Adult , Breast Neoplasms/diagnosis , Diagnosis, Differential , Female , HumansABSTRACT
The levels of tumor markers--CEA, ferritin and prolactin (the hormone of the anterior pituitary gland) were studied in the blood serum of 178 breast cancer patients in the menopause during combined therapy using a radioimmunoassay. This combination was shown to be informative for assessment of prognosis of disease and efficacy of antitumor therapy which was confirmed by clinical and x-ray findings and observation of a tumor process in breast cancer patients over a 5-year period.
Subject(s)
Biomarkers, Tumor/blood , Breast Neoplasms/therapy , Carcinoembryonic Antigen/blood , Ferritins/blood , Prolactin/blood , Breast Neoplasms/blood , Female , Humans , Prognosis , RadioimmunoassayABSTRACT
The levels of gonadotropic hormones, prolactin, carcinoembryonic antigen (CEA) and ferritin were measured in 111 females (52--cancer, 32--benign tumors and 27--healthy controls in menopause). Radioimmunologic study showed a significant increase in prolactin, CEA and ferritin levels in patients with T1-2N0M0 breast tumors.
